Publications - Ā mātou whakaputa
We publish a range of information, from strategies and plans to guidance for clinicians and other health service providers.
Pātiki and Waharua Kōpito patterns
All publications
241
to
250 of
675 publications
No results found.
-
National Bowel Screening Programme in Hauora a Toi Bay of Plenty (OIA - HNZ00009646)
This response provides information about the National Bowel Screening Programme in Hauora a Toi Bay of Plenty. -
Te Toka Tumai Auckland - COVID-19 testing site at Balmoral (OIA - HNZ00028950)
This response provides information about the COVID-19 testing site at 182 Balmoral Road, Mt Eden. -
Te Toka Tumai Auckland - Prioritisation of patients who may require chemotherapy work (OIA - HNZ00023560)
This response provides information about the prioritisation of patients who may require chemotherapy, the waitlist times and calculations. -
The Triennial Maternity Consumer Survey reports
These reports outline the results of the Maternity Consumer Surveys, which provide regular assessment of satisfaction with maternity services. -
Residential care facilities which have contracts with Te Whatu Ora within metropolitan Auckland and Capital, Coast and Hutt Valley (OIA - HNZ00022121)
This response provides information about the residential care facilities which have contracts with Te Whatu Ora within metropolitan Auckland and CCHV. -
Dioxins: A technical guide
This guide is for health professionals and others who have questions about the health effects of dioxins, and includes historic exposure incidents. -
Clinical Performance Report 1 April - 30 June 2023
-
New breast cancer diagnoses and treatments 2020
This report analyses 2020 breast cancer diagnoses nationally for women aged 45 to 69, across all referral sources. -
Te Tai o Poutini West Coast - Waitlist numbers for skin cancer and eye surgery (OIA - HNZ00014579)
This response provides information about the number of people waiting for skin cancer and eye surgery in Te Tai o Poutini West Coast. -
Communications policy with Pfizer (OIA - HNZ00027473)
This response provides information about Te Whatu Ora communications policy with Pfizer in relation to serious adverse events following immunisation.